Is ResMed Stock a Good Investment?
ResMed Investment Advice | RMD |
- Examine ResMed's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research ResMed's leadership team and their track record. Good management can help ResMed navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact ResMed's business and its evolving consumer preferences.
- Compare ResMed's performance and market position to its competitors. Analyze how ResMed is positioned in terms of product offerings, innovation, and market share.
- Check if ResMed pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about ResMed's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in ResMed Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if ResMed Inc is a good investment.
Sell | Buy |
Strong Buy
Market Performance | Solid | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Strong | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine ResMed Stock
Researching ResMed's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 65.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.66. ResMed Inc recorded earning per share (EPS) of 9.52. The entity last dividend was issued on the 14th of August 2025. The firm had 2:1 split on the 31st of August 2010.
To determine if ResMed is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ResMed's research are outlined below:
| ResMed Inc has a strong financial position based on the latest SEC filings | |
| About 65.0% of the company shares are owned by institutional investors | |
| On 12th of June 2025 ResMed paid $ 0.53 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands |
ResMed uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ResMed Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ResMed's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 25th of April 2024 Upcoming Quarterly Report | View | |
| 1st of August 2024 Next Financial Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View | |
| 1st of August 2024 Next Fiscal Year End | View | |
| 31st of December 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
ResMed's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 40.94 B.ResMed's profitablity analysis
The company has Net Profit Margin of 0.27 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.34 %, which entails that for every 100 dollars of revenue, it generated $0.34 of operating income.Determining ResMed's profitability involves analyzing its financial statements and using various financial metrics to determine if ResMed is a good buy. For example, gross profit margin measures ResMed's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ResMed's profitability and make more informed investment decisions.
Please note, the presentation of ResMed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ResMed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ResMed's management manipulating its earnings.
Basic technical analysis of ResMed Stock
As of the 4th of August, ResMed holds the Semi Deviation of 0.5163, risk adjusted performance of 0.2245, and Coefficient Of Variation of 354.3. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ResMed, as well as the relationship between them. Please check ResMed Inc information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if ResMed Inc is priced some-what accurately, providing market reflects its current price of 279.2 per share. Given that ResMed has jensen alpha of 0.2763, we recommend you to check out ResMed Inc's recent market performance to make sure the company can sustain itself at a future point.ResMed's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ResMed insiders, such as employees or executives, is commonly permitted as long as it does not rely on ResMed's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ResMed insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ResMed's Outstanding Corporate Bonds
ResMed issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ResMed Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ResMed bonds can be classified according to their maturity, which is the date when ResMed Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US76119LAB71 Corp BondUS76119LAB71 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand ResMed's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing ResMed's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.2245 | |||
| Market Risk Adjusted Performance | 17.38 | |||
| Mean Deviation | 0.7987 | |||
| Semi Deviation | 0.5163 | |||
| Downside Deviation | 0.8193 | |||
| Coefficient Of Variation | 354.3 | |||
| Standard Deviation | 1.02 | |||
| Variance | 1.04 | |||
| Information Ratio | 0.1711 | |||
| Jensen Alpha | 0.2763 | |||
| Total Risk Alpha | 0.144 | |||
| Sortino Ratio | 0.213 | |||
| Treynor Ratio | 17.37 | |||
| Maximum Drawdown | 4.41 | |||
| Value At Risk | (1.14) | |||
| Potential Upside | 2.23 | |||
| Downside Variance | 0.6712 | |||
| Semi Variance | 0.2666 | |||
| Expected Short fall | (1.01) | |||
| Skewness | 0.3706 | |||
| Kurtosis | 0.8368 |
| Risk Adjusted Performance | 0.2245 | |||
| Market Risk Adjusted Performance | 17.38 | |||
| Mean Deviation | 0.7987 | |||
| Semi Deviation | 0.5163 | |||
| Downside Deviation | 0.8193 | |||
| Coefficient Of Variation | 354.3 | |||
| Standard Deviation | 1.02 | |||
| Variance | 1.04 | |||
| Information Ratio | 0.1711 | |||
| Jensen Alpha | 0.2763 | |||
| Total Risk Alpha | 0.144 | |||
| Sortino Ratio | 0.213 | |||
| Treynor Ratio | 17.37 | |||
| Maximum Drawdown | 4.41 | |||
| Value At Risk | (1.14) | |||
| Potential Upside | 2.23 | |||
| Downside Variance | 0.6712 | |||
| Semi Variance | 0.2666 | |||
| Expected Short fall | (1.01) | |||
| Skewness | 0.3706 | |||
| Kurtosis | 0.8368 |
Consider ResMed's intraday indicators
ResMed intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ResMed stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
ResMed time-series forecasting models is one of many ResMed's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary ResMed's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
ResMed Stock media impact
There is far too much social signal, news, headlines, and media speculation about ResMed that are available to investors today. This information is accessible both publicly - through ResMed's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of ResMed-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of ResMed news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ResMed relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ResMed's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ResMed alpha.
ResMed Corporate Directors
| Ronald Taylor | Lead Independent Director | Profile | |
| Harjit Gill | Independent Director | Profile | |
| Carol Burt | Independent Director | Profile | |
| Jan Witte | Independent Director | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ResMed. If investors know ResMed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ResMed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ResMed Inc is measured differently than its book value, which is the value of ResMed that is recorded on the company's balance sheet. Investors also form their own opinion of ResMed's value that differs from its market value or its book value, called intrinsic value, which is ResMed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ResMed's market value can be influenced by many factors that don't directly affect ResMed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between ResMed's value and its price, as these two are different measures arrived at by various means. Investors typically determine if ResMed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ResMed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.